<DOC>
	<DOC>NCT02568358</DOC>
	<brief_summary>Lung transplantation (LTx) , DNA-based testing. Performance of DNA-based testing of bacterial and fungal pathogens in comparison to standard testing. Experimental intervention: DNA-based testing of BAL fluid.</brief_summary>
	<brief_title>DNA-based Testing in BAL of Lung Transplant Recipients With Suspected Non-viral Lower Respiratory Tract Infection</brief_title>
	<detailed_description>Cohen's kappa of any pathogen isolation by DNA-based testing vs. standard cultures in comparison to the final diagnosis of non-viral lower respiratory tract infection.</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>patients after lung transplantation (single, double or combined) suspicion of nonviral lower respiratory tract infection as defined by at least 2 out of new onset of malaise new or progressive pulmonary infiltrate hypoxemia (SpO2/SaO2 &lt;92% or need for oxygen) temperature of 38 o C or above within 7 days purulent (yellow or greenish) sputum CRP of 30 mg/l or above PCT of 0,5 Âµg/l or above no informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>